Ketamine monotherapy versus adjunctive ketamine in adults with treatment resistant depression: Results from the Canadian Rapid Treatment Centre of Excellence

Treatment Resistant ◽

Centre Of Excellence ◽

Treatment Centre ◽

Resistant Depression ◽

Rapid Treatment

Frequency Analysis of Symptomatic Worsening Following Ketamine Infusions For Treatment Resistant Depression in a Real-World Sample: Results From the Canadian Rapid Treatment Centre of Excellence

Psychiatry Research ◽

10.1016/j.psychres.2021.114321 ◽

2021 ◽

pp. 114321

Author(s):

Joshua D. Di Vincenzo ◽

Orly Lipsitz ◽

Nelson B. Rodrigues ◽

Brett D.M. Jones ◽

Hartej Gill ◽

...

Keyword(s):

Frequency Analysis ◽

Real World ◽

Treatment Resistant ◽

Centre Of Excellence ◽

Treatment Centre ◽

Resistant Depression ◽

Rapid Treatment

Intravenous ketamine for postmenopausal women with treatment-resistant depression: Results from the Canadian Rapid Treatment Center of Excellence

Journal of Psychiatric Research ◽

10.1016/j.jpsychires.2020.08.002 ◽

2020 ◽

Author(s):

Orly Lipsitz ◽

Roger S. McIntyre ◽

Nelson B. Rodrigues ◽

Yena Lee ◽

Danielle S. Cha ◽

...

Keyword(s):

Postmenopausal Women ◽

Treatment Center ◽

Treatment Resistant ◽

Center Of Excellence ◽

Resistant Depression ◽

Intravenous Ketamine ◽

Rapid Treatment

Supplemental Material for Personality and Outcome in Individuals With Treatment-Resistant Depression—Exploring Differential Treatment Effects in the Tavistock Adult Depression Study (TADS)

Journal of Consulting and Clinical Psychology ◽

10.1037/ccp0000391.supp ◽

2019 ◽

Keyword(s):

Treatment Effects ◽

Differential Treatment ◽

Treatment Resistant ◽

Adult Depression ◽

Optimizing the Effectiveness of Selective Serotonin Reuptake Inhibitors (SSRIs) in Treatment-Resistant Depression

PsycEXTRA Dataset ◽

10.1037/e651292010-001 ◽

2009 ◽

Author(s):

George I. Papakostas

Keyword(s):

Serotonin Reuptake ◽

Selective Serotonin Reuptake Inhibitors ◽

Serotonin Reuptake Inhibitors ◽

Selective Serotonin ◽

Treatment Resistant ◽

Treatment resistant depression (TRD): psychopathological profiles and pharmacological outcomes

10.26226/morressier.5785edc9d462b80296c9980d ◽

2016 ◽

Author(s):

Nicolas Nunez

Keyword(s):

Treatment Resistant ◽

Clinical and Neurocognitive Characteristics Associated With Treatment-Resistant Depression

10.26226/morressier.5885d713d462b8028d8910ee ◽

2017 ◽

Author(s):

Gianluca Serafini

Keyword(s):

Treatment Resistant ◽

Intravenous clomipramine for treatment resistant depression

10.26226/morressier.5971be83d462b80290b5308a ◽

2017 ◽

Author(s):

Irene Baldani

Keyword(s):

Treatment Resistant ◽

Safety and efficacy of ketamine infusion in treatment-resistant depression with metabolic syndrome and morbid obesity: a case report

10.26226/morressier.59d4913ad462b8029238a2d8 ◽

2017 ◽

Author(s):

Carolina Nakahira

Keyword(s):

Metabolic Syndrome ◽

Morbid Obesity ◽

Case Report ◽

Treatment Resistant ◽

Safety And Efficacy ◽

Ketamine Infusion ◽

Neurocognitive Characteristics of Patients With and Without Treatment-resistant Depression

10.26226/morressier.5a7070e3d462b80290b5662e ◽

2018 ◽

Author(s):

Gianluca Serafini

Keyword(s):

Treatment Resistant ◽

History of Ketamine and Itss New Role in Treatment Resistant Depression

10.26226/morressier.5a6ef3efd462b80290b589f1 ◽

2018 ◽

Author(s):

Roohi Abubaker

Keyword(s):

Treatment Resistant ◽

History Of ◽